175 related articles for article (PubMed ID: 32565543)
1. Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis.
Molica S; Giannarelli D
Leukemia; 2021 Feb; 35(2):615-618. PubMed ID: 32565543
[No Abstract] [Full Text] [Related]
2. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis.
Molica S; Giannarelli D; Mirabelli R; Levato L; Shanafelt TD
Ann Hematol; 2018 Oct; 97(10):2005-2008. PubMed ID: 29740683
[No Abstract] [Full Text] [Related]
4. Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia.
Miao Y; Fan L; Wu YJ; Xia Y; Qiao C; Wang Y; Wang L; Hong M; Zhu HY; Xu W; Li JY
Oncotarget; 2016 Mar; 7(12):13551-62. PubMed ID: 26910908
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
Asaad NY; Abd El-Wahed MM; Dawoud MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
[TBL] [Abstract][Full Text] [Related]
6. Assessing time to first treatment in early chronic lymphocytic leukemia (CLL): a comparative performance analysis of five prognostic models with inclusion of CLL-international prognostic index (CLL-IPI).
Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Morabito F
Leuk Lymphoma; 2017 Jul; 58(7):1736-1739. PubMed ID: 27875912
[No Abstract] [Full Text] [Related]
7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
8. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
[TBL] [Abstract][Full Text] [Related]
9. SnapShot: chronic lymphocytic leukemia.
Ciccone M; Ferrajoli A; Keating MJ; Calin GA
Cancer Cell; 2014 Nov; 26(5):770-770.e1. PubMed ID: 25517752
[TBL] [Abstract][Full Text] [Related]
10. The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis.
Molica S; Giannarelli D; Mirabelli R; Levato L; Shanafelt TD
Leuk Lymphoma; 2019 Jul; 60(7):1644-1649. PubMed ID: 30516079
[TBL] [Abstract][Full Text] [Related]
11. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia.
Oliveira AC; de la Banda E; Domingo-Domenech E; Encuentra M; Mercadal S; Domingo A; Alonso E; Espinet B; Grau J; De Sevilla AF; Gonzalez-Barca E
Leuk Lymphoma; 2011 Mar; 52(3):429-35. PubMed ID: 21323523
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of ATM mutations in chronic lymphocytic leukemia: A meta-analysis.
Baghaei Vaji F; Boroumand Nasr A; Rezvani A; Ayatollahi H; Goudarzi S; Lavasani S; Bagheri R
Leuk Res; 2021 Dec; 111():106729. PubMed ID: 34735935
[TBL] [Abstract][Full Text] [Related]
14. ZAP-70 levels do change in CLL but not very often.
Hamblin TJ
Leuk Lymphoma; 2007 Jun; 48(6):1059-60. PubMed ID: 17577764
[No Abstract] [Full Text] [Related]
15. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells.
Ocaña E; Delgado-Pérez L; Campos-Caro A; Muñóz J; Paz A; Franco R; Brieva JA
Haematologica; 2007 Mar; 92(3):349-56. PubMed ID: 17339184
[TBL] [Abstract][Full Text] [Related]
17. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
18. The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients.
Abramenko I; Bilous N; Chumak A; Kryachok I; Fedorenko Z; Martina Z; Dyagil I
Leuk Res; 2021 Nov; 110():106686. PubMed ID: 34492598
[TBL] [Abstract][Full Text] [Related]
19. [Multidrug resistance in chronic lymphocytic leukemia].
Szendrei T; Magyarlaki T; Kovács G; Nagy A; Szomor A; Molnár L; Dávid M; Tokés-Füzesi M; Rideg O; Pótó L; Pajor L; Kajtár B; Losonczy H
Orv Hetil; 2008 Jan; 149(4):161-7. PubMed ID: 18201958
[TBL] [Abstract][Full Text] [Related]
20. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
